Regulatory role of 1, 25-dihydroxyvitamin D3 and vitamin D receptor gene variants on intracellular granzyme A expression in pulmonary tuberculosis

被引:26
作者
Vidyarani, M. [1 ]
Selvaraj, P. [1 ]
Raghavan, S. [1 ]
Narayanan, P. R. [1 ]
机构
[1] Indian Council Med Res, TB Res Ctr, Dept Immunol, Madras 600031, Tamil Nadu, India
关键词
Granzyme A; 1; 25-dihydroxyvitamin D-3; Vitamin D receptor; Tuberculosis; LYMPHOCYTE SUBSETS; CYTOKINE RESPONSE; SUSCEPTIBILITY; POLYMORPHISMS; CELLS; ASSOCIATION; INTERFERON; ACTIVATION; RESISTANCE; CYTOLYSIS;
D O I
10.1016/j.yexmp.2008.10.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Vitamin D receptor (VDR) genotypes have been shown to be associated with differential susceptibility or resistance to tuberculosis. The influence of Fokl, Bsml, Apal and Taql variants of VDR gene on 1, 25(OH)(2) D-3 modulated granzyme A expression of cytotoxic lymphocytes induced by culture filtrate antigen (CFA) of Mycobacterium tuberculosis was studied in 40 pulmonary tuberculosis (PTB) patients and 49 normal healthy subjects (NHS) by flow cytometry. In both the study groups, addition of 1, 25(OH)(2) D-3 (10(-7)M) significantly reduced the percentage of granzyme A positive cells in both unstimulated (NHS, p<0.0001; PTB, p=0.02) and stimulated culture conditions (CFA, NHS, p<0.0001; PTB, p=0.0001) which correlated positively with the IFN-gamma levels (unstimulated, p=0.01; CFA stimulated, p=0.004) in NHS. The Apal as genotype and bbaaTT extended genotype were associated with a significantly decreased percentage of granzyme A positive cells in NHS (p<0.05). Our results suggest that 1, 25(OH)(2) D-3 suppresses granzyme A probably by down-regulating Th1 cytokine response. Moreover, the VDR gene variants might regulate cytotoxic T-cell response via 1, 25 (OH)(2) D-3 mediated suppression of granzyme A expression in tuberculosis. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 31 条
  • [1] Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation
    Beresford, PJ
    Xia, ZN
    Greenberg, AH
    Lieberman, J
    [J]. IMMUNITY, 1999, 10 (05) : 585 - 594
  • [2] Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7
  • [3] 1,25(OH)2D3 PRODUCTION BY LYMPHOCYTE-T AND ALVEOLAR MACROPHAGES RECOVERED BY LAVAGE FROM NORMOCALCEMIC PATIENTS WITH TUBERCULOSIS
    CADRANEL, J
    GARABEDIAN, M
    MILLERON, B
    GUILLOZO, H
    AKOUN, G
    HANCE, AJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) : 1588 - 1593
  • [4] The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels
    Correa, P
    Rastad, J
    Schwarz, P
    Westin, G
    Kindmark, A
    Lundgren, E
    Åkerström, G
    Carling, T
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) : 1690 - 1694
  • [5] Vitamin D: its role and uses in immunology
    Deluca, HF
    Cantorna, MT
    [J]. FASEB JOURNAL, 2001, 15 (14) : 2579 - 2585
  • [6] Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A
    Fan, ZS
    Beresford, PJ
    Zhang, D
    Xu, Z
    Novina, CD
    Yoshida, A
    Pommier, Y
    Lieberman, J
    [J]. NATURE IMMUNOLOGY, 2003, 4 (02) : 145 - 153
  • [7] Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells
    Grossman, WJ
    Verbsky, JW
    Tollefsen, BL
    Kemper, C
    Atkinson, JP
    Ley, TJ
    [J]. BLOOD, 2004, 104 (09) : 2840 - 2848
  • [8] The genomics and genetics of human infectious disease susceptibility
    Hill, AVS
    [J]. ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2001, 2 : 373 - 400
  • [9] Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity
    Imazeki, Ikuo
    Matsuzaki, Junko
    Tsuji, Keiko
    Nishimura, Takashi
    [J]. BIOMEDICAL RESEARCH-TOKYO, 2006, 27 (01): : 1 - 9
  • [10] Jans DA, 1998, J CELL SCI, V111, P2645